Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (31-40 of 451) with videos related to

Pageof 46
Sort By:
Annals of Internal Medicine|June 5, 2023
In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract diseaseMelina Awar, Eleftherios Mylonakis
Virulence|December 24, 2010
From the outside in and the inside out: Antifungal immune responses in Caenorhabditis elegansRead Pukkila-Worley, Eleftherios Mylonakis
Medicine|May 9, 2020
Web search popularity, publicity, and utilization of direct oral anticoagulants in the United States, 2008-2018: A STROBE-compliant studyPanayiotis D Ziakas, Eleftherios Mylonakis
AMA Journal of Ethics|August 30, 2021
How Should Economic Analyses Inform Nosocomial Infection Control?Eleftherios Mylonakis, Panayiotis D Ziakas
Expert Opinion on Pharmacotherapy|March 4, 2008
Epidemiology and management of cryptococcal meningitis: developments and challengesRead Pukkila-Worley, Eleftherios Mylonakis
Expert Opinion on Pharmacotherapy|May 23, 2007
Posaconazole: a new broad-spectrum antifungal agentDouglas S Kwon, Eleftherios Mylonakis
Annals of Internal Medicine|October 17, 2018
Procalcitonin-guided antibiotic prescribing did not reduce antibiotic use in suspected LRTI in the EDGiannoula S Tansarli, Eleftherios Mylonakis
PLOS Digital Health|March 12, 2024
Public interest trends for COVID-19 and pandemic trajectory: A time-series analysis of US state-level dataPanayiotis D Ziakas, Eleftherios Mylonakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicityPanayiotis D Ziakas, Eleftherios Mylonakis
Virulence|April 2, 2015
Oral infections: clinical and biological perspectivesGeorgios N Belibasakis, Eleftherios Mylonakis
Pageof 46

Showing results (31-40 of 451) with videos related to

Sort By:
Pageof 46
Annals of Internal Medicine|June 5, 2023
In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract diseaseMelina Awar, Eleftherios Mylonakis
Virulence|December 24, 2010
From the outside in and the inside out: Antifungal immune responses in Caenorhabditis elegansRead Pukkila-Worley, Eleftherios Mylonakis
Medicine|May 9, 2020
Web search popularity, publicity, and utilization of direct oral anticoagulants in the United States, 2008-2018: A STROBE-compliant studyPanayiotis D Ziakas, Eleftherios Mylonakis
AMA Journal of Ethics|August 30, 2021
How Should Economic Analyses Inform Nosocomial Infection Control?Eleftherios Mylonakis, Panayiotis D Ziakas
Expert Opinion on Pharmacotherapy|March 4, 2008
Epidemiology and management of cryptococcal meningitis: developments and challengesRead Pukkila-Worley, Eleftherios Mylonakis
Expert Opinion on Pharmacotherapy|May 23, 2007
Posaconazole: a new broad-spectrum antifungal agentDouglas S Kwon, Eleftherios Mylonakis
Annals of Internal Medicine|October 17, 2018
Procalcitonin-guided antibiotic prescribing did not reduce antibiotic use in suspected LRTI in the EDGiannoula S Tansarli, Eleftherios Mylonakis
PLOS Digital Health|March 12, 2024
Public interest trends for COVID-19 and pandemic trajectory: A time-series analysis of US state-level dataPanayiotis D Ziakas, Eleftherios Mylonakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicityPanayiotis D Ziakas, Eleftherios Mylonakis
Virulence|April 2, 2015
Oral infections: clinical and biological perspectivesGeorgios N Belibasakis, Eleftherios Mylonakis
Pageof 46